COVID-19 trials: declarations of data sharing intentions at trial registration and at publication
Abstract Background The sharing of individual participant-level data from COVID-19 trials would allow re-use and secondary analysis that can help accelerate MAGNESIUM CITRATE the identification of effective treatments.The sharing of trial data is not the norm, but the unprecedented pandemic caused by SARS-CoV-2 may serve as an impetus for greater d